Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Haoran
Haoran Wang, Kowloon CN
| Patent application number | Description | Published |
|---|---|---|
| 20100265668 | FLEXIBLE DISPLAY SCREEN - A flexible display screen includes a plurality of flexible display modules joined side by side, each flexible display module having a flexible circuit board, which is fixedly arranged with a plurality of display chips on its front face, and a plurality of magnets on its back face, so that the flexible display screen can be attracted on a metal medium by the magnets, wherein the magnets are distributed at least on the perimeter of the back face of the flexible circuit board so that the joining sides of two adjoining flexible circuit boards are arranged respectively and symmetrically with a same number of magnets, and each pair of magnets disposed on the respective joining sides having opposite polarity orientations. | 10-21-2010 |
Haoran Wang, Shenzhen CN
| Patent application number | Description | Published |
|---|---|---|
| 20080316153 | Flexible LED Screen - A flexible LED screen includes a flexible printed circuit board having a front surface and a rear surface, a plurality of SMT-LEDs mounted on the front surface of the flexible printed circuit board, and a plurality of integrated circuits mounted on the rear surface of the flexible printed circuit board. | 12-25-2008 |
Haoran Wu, Blacksburg, VA US
| Patent application number | Description | Published |
|---|---|---|
| 20110291574 | MULTI-CHANNEL CONSTANT CURRENT SOURCE AND ILLUMINATION SOURCE - A multi-channel circuit having respective channels powered through transformers having primary windings connected in series allows substantially equal constant currents to be provided through all channels by cross-regulation while only a single channel need be monitored and controlled. The variation in current between channels is generally small and largely insensitive to imbalances between voltages on loads due, for example, to different numbers of LEDs in series connected strings in illumination devices and can be further reduced by inverse coupling between inductors in respective channels. Efficiency is improved through reduction in the number of stages of the constant current source since the respective channels provided both DC-to-DC conversion and constant current regulation. | 12-01-2011 |
Haoran Zhao, Foster City, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080260719 | EDG: Modulators of lymphocyte activation and migration - The present invention relates to regulation of lymphocyte activation and migration. More particularly, the present invention is directed to nucleic acids encoding EDG family GPCR proteins, e.g., EDG-1, 2, 3, 4, 5, 6, 7, or 8, which are involved in modulation of lymphocyte activation and migration. The invention further relates to methods for identifying and using agents, including small organic molecules, antibodies, peptides, cyclic peptides, nucleic acids, antisense nucleic acids, sphingolipid analogs, and ribozymes, that modulate lymphocyte activation or migration via modulation of EDG GPCRs and EDG related signal transduction; as well as to the use of expression profiles and compositions in diagnosis and therapy related to lymphocyte activation and suppression, and lymphocyte migration. | 10-23-2008 |
| 20100130486 | CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC INHIBITORS - The invention encompasses compounds having formula I or II and the compositions and methods using these compounds in the treatment of conditions in which inhibition of PKC and PKD is therapeutically useful. | 05-27-2010 |
| 20100152172 | 2,4-PYRIMIDINEDIAMINE COMPOUNDS FOR TREATING OR PREVENTING AUTOIMMUNE DISEASES - The present invention provides 3-hydroxyphenyl-2,4-pyrimidinediamine compounds of formula I, as well as related compositions and methods for treating a variety of autoimmune diseases. | 06-17-2010 |
| 20100184755 | PROTEIN KINASE C INHIBITORS AND USES THEREOF - This disclosure concerns compounds which are useful as inhibitors of protein kinase C (PKC) and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC. This disclosure also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes. | 07-22-2010 |
| 20100204208 | PROTEIN KINASE C INHIBITORS AND USES THEREOF - This disclosure concerns compounds which are useful as inhibitors of protein kinase C (PKC) and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC. This disclosure also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes. | 08-12-2010 |